CJC-1295 / Ipamorelin Blend

CJC-1295 (No DAC) is an analog of growth hormone releasing hormone and acts at GHRH receptors on the pituitary. Ipamorelin acts on a separate receptor family, promoting growth hormone release through a ghrelin mediated pathway. Because the two compounds engage distinct receptor systems, the blend is studied for its potential to increase pulsatile growth hormone output.

Research on this combination examines downstream signaling tied to cellular repair, metabolism, and tissue homeostasis, including bone density pathways, lean tissue development, fat metabolism signaling, immune modulation, and recovery mechanisms.

Areas of Research Interest

• CJC-1295 (No DAC): GHRH receptor stimulation and its effect on pituitary growth hormone signaling.
• Ipamorelin: Selective growth hormone secretagogue activity through the ghrelin receptor pathway.